2005P-0411
  

  
 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs 

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2681
  



  

  
Submitter : 
  

  
Dr. James Mahoney
  

  
Date & Time: 
  

  
02/16/2006 02:02:38
  



  

  
Organization : 
  

  
Center for Hope and Healing
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Compounding pharmacies have been tremendously supportive of women's health in my practice and have created an opportunity for many to have complete reversal of their life-altering menopausal symtpoms without the undue risks associated with non-human type hormones.  It is beyond my understanding that the FDA would make the assumption that these compounds that we are individualizing for women with painstaking precision would be an endangerment to public health.  On the contrary we are now able to offer a safe viable alternative to conjugated equine estrogens that completely resolve symptoms while closely mimcing normal human physiology.